NCCN Asian Consensus Statement - Can Asian patients with cancer accept treatment modalities from NCCN guidelines?

Seiichiro Ozono, Shiro Hinotsu, Mikio Namiki, Hideyuki Akaza

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

To spread the National Comprehensive Cancer Network (NCCN) guidelines widely in Asia, committee members from Asian countries have been preparing an Asia Consensus Statement (ACS) along the NCCN guidelines. The ACS for Kidney Cancer guidelines and Prostate Cancer guidelines were issued in 2009 and in 2011, respectively. In addition, second versions of both these guidelines were issued in 2011 and 2013, respectively. In this review, the process and contents of NCCN ACS have been described.

Original languageEnglish
Pages (from-to)683-686
Number of pages4
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume41
Issue number6
Publication statusPublished - 2014

Fingerprint

Guidelines
Neoplasms
Prostatic Neoplasms
Committee Membership
Therapeutics
Kidney Neoplasms

Keywords

  • Asia Consensus Statement (ACS)
  • Guideline
  • NCCN

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

NCCN Asian Consensus Statement - Can Asian patients with cancer accept treatment modalities from NCCN guidelines? / Ozono, Seiichiro; Hinotsu, Shiro; Namiki, Mikio; Akaza, Hideyuki.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 41, No. 6, 2014, p. 683-686.

Research output: Contribution to journalArticle

Ozono, Seiichiro ; Hinotsu, Shiro ; Namiki, Mikio ; Akaza, Hideyuki. / NCCN Asian Consensus Statement - Can Asian patients with cancer accept treatment modalities from NCCN guidelines?. In: Gan to kagaku ryoho. Cancer & chemotherapy. 2014 ; Vol. 41, No. 6. pp. 683-686.
@article{59d8b697240c4473a2eea214f3b59dd6,
title = "NCCN Asian Consensus Statement - Can Asian patients with cancer accept treatment modalities from NCCN guidelines?",
abstract = "To spread the National Comprehensive Cancer Network (NCCN) guidelines widely in Asia, committee members from Asian countries have been preparing an Asia Consensus Statement (ACS) along the NCCN guidelines. The ACS for Kidney Cancer guidelines and Prostate Cancer guidelines were issued in 2009 and in 2011, respectively. In addition, second versions of both these guidelines were issued in 2011 and 2013, respectively. In this review, the process and contents of NCCN ACS have been described.",
keywords = "Asia Consensus Statement (ACS), Guideline, NCCN",
author = "Seiichiro Ozono and Shiro Hinotsu and Mikio Namiki and Hideyuki Akaza",
year = "2014",
language = "English",
volume = "41",
pages = "683--686",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "6",

}

TY - JOUR

T1 - NCCN Asian Consensus Statement - Can Asian patients with cancer accept treatment modalities from NCCN guidelines?

AU - Ozono, Seiichiro

AU - Hinotsu, Shiro

AU - Namiki, Mikio

AU - Akaza, Hideyuki

PY - 2014

Y1 - 2014

N2 - To spread the National Comprehensive Cancer Network (NCCN) guidelines widely in Asia, committee members from Asian countries have been preparing an Asia Consensus Statement (ACS) along the NCCN guidelines. The ACS for Kidney Cancer guidelines and Prostate Cancer guidelines were issued in 2009 and in 2011, respectively. In addition, second versions of both these guidelines were issued in 2011 and 2013, respectively. In this review, the process and contents of NCCN ACS have been described.

AB - To spread the National Comprehensive Cancer Network (NCCN) guidelines widely in Asia, committee members from Asian countries have been preparing an Asia Consensus Statement (ACS) along the NCCN guidelines. The ACS for Kidney Cancer guidelines and Prostate Cancer guidelines were issued in 2009 and in 2011, respectively. In addition, second versions of both these guidelines were issued in 2011 and 2013, respectively. In this review, the process and contents of NCCN ACS have been described.

KW - Asia Consensus Statement (ACS)

KW - Guideline

KW - NCCN

UR - http://www.scopus.com/inward/record.url?scp=84906232308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906232308&partnerID=8YFLogxK

M3 - Article

C2 - 25129079

AN - SCOPUS:84906232308

VL - 41

SP - 683

EP - 686

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 6

ER -